INSULATARD

This brand name is authorized in Austria, Croatia, Cyprus, Estonia, France, Germany, Ireland, Israel, Lithuania, Netherlands, Nigeria, Poland, Romania, Singapore, Spain, Tunisia, Turkey, UK.

Active ingredients

The drug INSULATARD contains one active pharmaceutical ingredient (API):

1
UNII 1Y17CTI5SR - INSULIN HUMAN
 

The blood glucose lowering effect of insulin is due to the facilitated uptake of glucose following binding of insulin to receptors on muscle and fat cells and to the simultaneous inhibition of glucose output from the liver.

 
Read more about Insulin (human)

Medication package inserts

Below package inserts are available for further reading:

Document Type Information Source  
 INSULATARD Suspension for injection MPI, EU: SmPC European Medicines Agency (EU)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group Classification
A10AC01 Insulin (human) A Alimentary tract and metabolism → A10 Drugs used in diabetes → A10A Insulins and analogues → A10AC Insulins and analogues for injection, intermediate-acting
Discover more medicines within A10AC01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
DE Bundesinstitut für Arzneimittel und Medizinprodukte 00022958, 00022964, 00115039, 00115335, 00292161, 00579916, 00702251, 01825487, 01825493, 05039656, 05039722, 06430776, 06430807, 09012708, 10206091
EE Ravimiamet 1202757, 1202768, 1202779, 1202780, 1202791, 1202803, 1202814, 1202847, 1202858, 1202869, 1202870, 1202881, 1202892
ES Centro de información online de medicamentos de la AEMPS 02233003, 02233014
FR Base de données publique des médicaments 60423446, 62457123, 67248825, 69704932
GB Medicines & Healthcare Products Regulatory Agency 32562, 32616, 32640
IE Health Products Regulatory Authority 61786, 71512, 71580
IL מִשְׂרַד הַבְּרִיאוּת 2576, 664
LT Valstybinė vaistų kontrolės tarnyba 1029202, 1029203, 1029204, 1029205, 1029206, 1029207, 1029208, 1029209, 1029210, 1029211, 1029212, 1029213, 1029214, 1029215, 1029216, 1029217, 1029218
NG Registered Drug Product Database A6-0450
Switch country to Nigeria in order to find specific presentations of INSULATARD
NL Z-Index G-Standaard 14815974, 14815982, 14994658, 14996839
NL Z-Index G-Standaard, PRK 105716, 29998, 34851
PL Rejestru Produktów Leczniczych 100030920, 100030943, 100030966, 100103174, 100311033
RO Agenția Națională a Medicamentului și a Dispozitivelor Medicale W03713002, W03713003, W03714001, W03714002, W03714003, W13941001, W13941002, W13941003, W52580001, W52580002, W52580003, W52581002, W52581003, W52581004, W52582002, W52582003, W52582004
SG Health Sciences Authority 08654P, 08655P
TN Direction de la Pharmacie et du Médicament 5993017, 5993026
TR İlaç ve Tıbbi Cihaz Kurumu 8699676770489, 8699676950416

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.